Read Time:12 Second
Shares of Baxter International Inc. gained ground early Tuesday, after the healthcare-products company announced an agreement to sell its kidney-care business — to be named Vantive — to private-equity investor Carlyle Group Inc. in a deal valued at $3.8 billion.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
